Lindbrook Capital, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$22,126
+45.2%
247
+38.0%
0.00%0.0%
Q2 2023$15,240
+2.9%
1790.0%0.00%0.0%
Q1 2023$14,812
+41.6%
179
+34.6%
0.00%
+100.0%
Q4 2022$10,460
+248.7%
133
+195.6%
0.00%0.0%
Q3 2022$3,000
+200.0%
45
+125.0%
0.00%
Q2 2022$1,0000.0%20
+33.3%
0.00%
Q1 2022$1,000
-66.7%
15
-65.9%
0.00%
-100.0%
Q3 2021$3,000
+200.0%
44
+300.0%
0.00%
Q1 2021$1,0000.0%11
+83.3%
0.00%
Q2 2020$1,0000.0%60.0%0.00%
Q1 2020$1,00060.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders